- Home
- ASND vs OWL Comparison
ASND vs OWL Comparison
Compare ASND & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- OWL
- Stock Information
- Founded
- ASND 2006
- OWL 2020
- Country
- ASND Denmark
- OWL United States
- Employees
- ASND N/A
- OWL N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- OWL Investment Managers
- Sector
- ASND Health Care
- OWL Finance
- Exchange
- ASND Nasdaq
- OWL Nasdaq
- Market Cap
- ASND 10.6B
- OWL 12.1B
- IPO Year
- ASND 2015
- OWL N/A
- Fundamental
- Price
- ASND $195.58
- OWL $18.76
- Analyst Decision
- ASND Strong Buy
- OWL Strong Buy
- Analyst Count
- ASND 16
- OWL 14
- Target Price
- ASND $240.75
- OWL $24.81
- AVG Volume (30 Days)
- ASND 418.2K
- OWL 7.4M
- Earning Date
- ASND 11-13-2025
- OWL 10-30-2025
- Dividend Yield
- ASND N/A
- OWL 4.80%
- EPS Growth
- ASND N/A
- OWL 20.13
- EPS
- ASND N/A
- OWL 0.11
- Revenue
- ASND $576,332,355.00
- OWL $2,618,831,000.00
- Revenue This Year
- ASND $101.37
- OWL $17.63
- Revenue Next Year
- ASND $76.17
- OWL $22.93
- P/E Ratio
- ASND N/A
- OWL $164.23
- Revenue Growth
- ASND 54.50
- OWL 31.81
- 52 Week Low
- ASND $111.09
- OWL $14.55
- 52 Week High
- ASND $208.16
- OWL $26.73
- Technical
- Relative Strength Index (RSI)
- ASND 52.37
- OWL 50.77
- Support Level
- ASND $196.06
- OWL $17.25
- Resistance Level
- ASND $202.57
- OWL $19.05
- Average True Range (ATR)
- ASND 6.49
- OWL 0.46
- MACD
- ASND -0.82
- OWL 0.06
- Stochastic Oscillator
- ASND 34.34
- OWL 83.84
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.